WHO Maintains Controversial Corona Vaccine AstraZeneca

The World Health Organization (WHO) still maintains its opinion that the AstraZeneca corona vaccine benefits outweigh the risks.

WHO does not expect it to be necessary to change its assessment, said a director of the organization.

Together with European and other regulators, the WHO is closely examining the latest data, following reports of blood clots in people who have been vaccinated. The WHO director responded to statements made by the leader of the vaccine evaluation team of the European medicines watchdog EMA.

He said there is a clear “link” between the AstraZeneca vaccine and very rare blood clots in the brain, although the direct cause of the blood clots is still unknown.

EMA later stated that it was still working on new research into the vaccine. The medicines agency expects to announce its findings on Wednesday or Thursday.